|
|
|
|
Drugs have become more lipophilic and complex in structure over time due to the industry’s move away from natural products. Despite this shift, fully synthetic drugs continue to grow in diversity and complexity. New strategies are needed to improve bioavailability of these drugs.
|
|
|
|
|
This poster demonstrates the application of in vitro flux assays to nanoparticles, with data on how the in vitro permeability apparatus can be utilized to characterize the membrane flux performance of an API formulated as a nanosuspension.
|
|
|
|
|
Nanoforming can open up exciting new opportunities – from increasing bioavailability to enabling sustained drug delivery. Discover the benefits that can be unlocked for both patients and the planet through the Nanoform toolbox, supported by data from relevant case studies.
|
|
|
|
|
|
|
